MENA Consumer & Retail: Resilient Q1 Earnings Mask Cost Headwinds; Overweight Nahdi & Almarai Offer Superior Earnings Visibility

Core Thesis

MENA consumer stocks delivered a strong Q1 2026 earnings season, with nearly all names beating net profit consensus. Yet stock price reactions have been muted or negative, implying the market expects earnings to degrade as conflict-related cost pressures materialize. We believe this perception is broadly correct—but not uniformly. The key differentiation is pricing power and domestic exposure. We remain Overweight on Nahdi (4164.SE) and Almarai (2280.SE), and are increasingly constructive on Equal-weight rated Savola (2050.SE). The sector’s valuation has de-rated to near 10-year lows (MENA Consumer NTM P/E 16.1x vs. 10Y avg 20.1x, 11th percentile), creating an attractive entry for names with resilient earnings profiles.

What the Market Underestimates

Investors are extrapolating conflict impact as a uniform drag. Three nuances are being overlooked:

• Cost headwinds are gradual, not immediate. Q1 results saw minimal freight/commodity pass-through due to pre-Ramadan inventory buffers and hedging. The pain begins Q2 onward, particularly Q3–Q4 as hedges roll off. But domestic-focused names (Nahdi, Almarai) face lower absolute freight exposure than multinational peers (Americana).
• Pricing power is a stark differentiator. Savola and Americana have already announced price increases. Almarai has not yet raised fresh dairy prices—a key optionality that, if executed, could offset margin compression. Nahdi operates in a competitive pharmacy retail environment, limiting pricing flexibility, but its full Saudi exposure means input cost inflation is narrower.
• Saudi consumption remains robust. Point-of-sale spend data around Eid showed aggregate +2% YoY (SAR 43.9bn). Electronics (+21%), health (+9%), and food & beverage (+8%) all grew. The softness is concentrated in tourist areas (Dubai) and in-home vs. out-of-home channel shifts, which we view as transitory.

Evidence Chain

1. Resilient Q1 earnings, but stock reactions discount a step-down.
Every covered company beat or met Q1 net profit consensus: Americana +26%, Jarir +20%, Savola +13%, eXtra +8%, Almarai +2%, Nahdi -7% (only miss). Yet one-day stock price moves ranged from -1% (Nahdi) to +10% (Americana), and quarter-to-date many are negative (Savola -8%, Almarai -6%). This divergence signals investors price in mean reversion.

2. Supply chain disruption is real but manageable—so far.
Companies adjusted via land routes and Red Sea ports, drawing on high Ramadan inventories. However, as inventory normalizes and hedging horizons shorten, freight and commodity cost pass-through will hit P&L from Q2 2026, accelerating into H2.

3. Saudi consumer sentiment has modestly weakened but remains above pre-conflict lows.
An Ipsos survey shows a slight dip after conflict onset, yet high oil prices (Brent ~$75) continue to support fiscal spending and domestic demand. Equity-valuation decoupling from oil (MENA Consumer P/E vs. Brent chart) suggests geopolitical fear, not fundamental deterioration.

4. Valuation is cheap on absolute and relative bases.
KSA Consumer sector trades at 16.1x NTM P/E, well below 10-year average of 20.1x (11th percentile). Sub-sectors near bottom: Food Producers (Almarai at 1st percentile), Pharmacies (Nahdi at 6th, Al-Dawaa at 4th), Restaurants (Americana at 9th). FCF yields are compelling: Nahdi 7.8%, Al-Dawaa 7.3%, eXtra 5.9%, Almarai 5.4%.

5. Consensus EPS expectations remain above our forecasts.
For every name, the analyst team’s 2026 EPS is below FactSet consensus (Americana -5.6%, Almarai -3.8%, Nahdi -2.2%), reflecting a more cautious view on margin erosion. The upside risk is if companies execute pricing more aggressively than modeled.

Key Divergences and Risks

• Pricing power asymmetry. Savola and Americana have publicly raised prices. Almarai’s ability to raise fresh dairy remains pivotal—if it fails, margin compression will be deeper. Nahdi faces structural headwinds from Wasfaty entry (potential margin dilution) and quick commerce competition, though its debt-free balance sheet offers flexibility.
• Wasfaty pharmacy competition. Nahdi entered the programme in October 2025, gaining share but at the expense of Al-Dawaa (downgraded to Equal-weight). Programme margin impact and working capital drag need monitoring.
• iPhone cycle dependency. Jarir and eXtra both rely heavily on iPhone sales (part of +9.7% and +8.4% retail growth in 2025). Apple’s direct entry into Saudi with physical stores in 2026 represents a medium-term market share risk. Sustainably high iPhone growth is uncertain.
• Americana cost exposure. As a QSR operator with high freight and fuel exposure, Americana is most vulnerable to input inflation. Its 1Q26 gross margin of ~56% may prove unsustainable; we expect EBITDA margin to contract 50-100bps y/y in 2026.
• Macro escalation. A broader conflict or sustained oil price decline would hit Saudi consumer confidence and fiscal multipliers, affecting all names.

Valuation and Trading Implications

Our preference:

• Overweight Nahdi – Best-in-class FCF yield, debt-free, domestic-only cost exposure, with optionality from GLP-1 adoption and Wasfaty.
• Overweight Almarai – Extreme valuation discount (1st percentile) vs. history; pricing power is the key swing factor. If a price increase is executed, EPS upgrades follow.
• Increasingly constructive on Savola – The simplification story (Turkey de-consolidation, food portfolio exits) combined with pricing power in sugar/oil supports margin recovery. Equal-weight for now, but we see upside risk.

Risks to overweight views: Failure to pass through costs (Almarai), competitive disruption in pharmacy (Nahdi), or a prolonged conflict that depresses Saudi spending.

---

Appendix: None required beyond the table above due to character constraints.